Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA)

CAPS Rating: 1 out of 5

A biopharmaceutical company focused on the development and commercialization of clinical-stage drug candidates, with exclusive worldwide commercial rights to three product candidates in clinical development for various central nervous system disorders.

Recs

2
Player Avatar hlacheen (98.88) Submitted: 2/14/2007 12:29:50 AM : Underperform Start Price: $27.77 VNDA Score: +87.72

Utter garbage.... like most pharmaceutical companies with huge losses and horrible balance sheets.

Member Avatar JANZZEN (60.45) Submitted: 4/28/2010 5:14:56 PM
Recs: 0

Big doubts ... Morningstar gave it 5 stars this week (april 2010)...

Featured Broker Partners


Advertisement